Basolateral amygdala opioids contribute to increased high-fat intake following intra-accumbens opioid administration, but not following 24-h food deprivation

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Previous research has demonstrated that administration of μ-opioid receptor agonists into the nucleus accumbens increases high-fat diet consumption in sated rats and has shown a role of basolateral amygdala (BLA) activity in mediating this response. The present experiments were conducted to examine the role of BLA opioid transmission in mediating high-fat feeding driven by either intra-accumbens opioid activation or 24-h home cage food deprivation. Injection of the μ-opioid agonist, d-Ala2-NMe-Phe4-Glyol5-enkephalin (DAMGO) into the nucleus accumbens (0.25μg/0.5μl/side) increased consumption of a high-fat diet, and this effect was attenuated by pre-treatment with the opioid antagonist, naltrexone (5μg/0.25μl/side) administered into the BLA. In contrast, intra-BLA naltrexone administration had no influence on the increase in high-fat intake following 24-h food deprivation. These findings suggest that BLA opioid transmission is an important mediator of palatability-driven feeding as modeled by intra-accumbens opioid activation, while BLA opioid transmission has no significant influence on the increase in high-fat feeding driven by short-term negative-energy balance.

Original languageEnglish
Pages (from-to)262-266
Number of pages5
JournalPharmacology Biochemistry and Behavior
Volume97
Issue number2
DOIs
StatePublished - Dec 2010

Keywords

  • Basolateral amygdala
  • DAMGO
  • Feeding
  • Food deprivation
  • High-fat diet
  • Naltrexone
  • Nucleus accumbens
  • Opioids

Fingerprint

Dive into the research topics of 'Basolateral amygdala opioids contribute to increased high-fat intake following intra-accumbens opioid administration, but not following 24-h food deprivation'. Together they form a unique fingerprint.

Cite this